Published in:
Open Access 01-12-2020 | Myocardial Infarction | Case report
Low dose combined oral contraceptives induced thrombotic anterior wall myocardial infarction: a case report
Published in: BMC Cardiovascular Disorders | Issue 1/2020
Login to get accessAbstract
Background
Combined oral contraceptive pills are associated with an established risk for venous thrombosis; however, their risk for arterial thrombosis remains uncertain, especially with the development of low dose new generations of combined oral contraceptive. Arterial thrombosis is less likely to occur with the use of oral contraceptive pills in the absence of cardiovascular risk factors.
Case presentation
We report a 35-year old female with no cardiovascular risk factors who presented with thrombotic anterior wall myocardial infarction 6 months after using a third generation low dose combined oral contraceptive pills (Marvelon; ethinylestradiol 30 mcg and desogestrel 150 mcg).
Conclusion
Third generation low dose combined oral contraceptives may lead to myocardial infarction in young women, even in the absence of other cardiovascular risk factors.